Skip to content

Clinical trials

Burkitt Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Country / region: China Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20151
20163
20175
20186
20198
20206
20217
202212
20234
202418
202519
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status40
Recruiting35
Not yet recruiting10
Active, not recruiting5
Completed4
Withdrawn4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The First Affiliated Hospital of Soochow University9
Institute of Hematology & Blood Diseases Hospital, China7
Zhejiang University6
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China4
Shenzhen BinDeBio Ltd.4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology4
Beijing GoBroad Hospital3
Hebei Yanda Ludaopei Hospital3
Anhui Provincial Hospital2
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma100
Lymphoma, B-Cell24
Recurrence11
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Lymphoma7
Multiple Myeloma6
Leukemia, Myeloid, Acute4
Lymphoma, Large B-Cell, Diffuse4
Leukemia3
Lymphoma, Follicular3

Trials

Showing 76 to 100 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.